Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomolecular pathogenesis of borderline ovarian tumors: focusing target discovery through proteogenomics.

Current cancer drug targets - 1 Feb 2010

Vergara D, Tinelli A, Martignago R, Malvasi A, Chiuri V E, Leo G

Abstract excerpt

Tumors of the epithelial surface account for about 80% of all ovarian neoplasms and exhibit a heterogeneous histological classification affecting survival. Tumors of low malignant potential, defined as borderline ovarian tumors(BOTs), have a markedly better survival and low recurrence, even if surgery still represents the common management for this type of cancer. It is still debated in the literature if BOTs can...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cystadenocarcinoma, Serous
Share to Genomic Instability

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ovarian Neoplasms

Share to Precancerous Conditions

Share to Proteomics

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Source

Identifiers

PMID: 20088785
DOI: 10.2174/156800910790980269

Genes

BRAF
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomolecular pathogenesis of borderline ovarian tumors: focusing target discovery through proteogenomics.PMID 20088785Read ↗

Molecular Landscape of Borderline Ovarian Tumors: A Systematic ReviewSemantic proximity Read ↗

Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges.Semantic proximity Read ↗

[Molecular pathology of epithelial ovarian neoplasias: from the phenotype-genotype correlation to new targets in diagnostics and therapy].Semantic proximity Read ↗

Proteomic analysis reveals potential biomarker candidates in serous ovarian tumors – a preliminary studySemantic proximity Read ↗

Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.Semantic proximity Read ↗

[Molecular characterization of epithelial ovarian borderline tumors with respect to clinical management and prognosis].Semantic proximity Read ↗

Somatic Genomic and Transcriptomic Characterization of Primary Ovarian Serous Borderline Tumors and Low-Grade Serous Carcinomas.Semantic proximity Read ↗

Low-grade serous ovarian carcinoma: an evolution toward targeted therapy.Semantic proximity Read ↗

Current update on borderline ovarian neoplasms.Semantic proximity Read ↗

An Analysis of Genetic Polymorphisms in 76 Genes Related to the Development of Ovarian Tumors of Different Aggressiveness.Semantic proximity Read ↗

Ovarian carcinoma: pathology review with an emphasis in their molecular characteristicsSemantic proximity Read ↗

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and TreatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.